Teriparatide Acetate Inj.100 "Asahi Kasei" (テリパラチド酢酸塩静注用100「旭化成」)

البلد: اليابان

اللغة: الإنجليزية

المصدر: すりの適正使用協議会 RAD-AR Council, Japan

العنصر النشط:

Teriparatide acetate

متاح من:

Asahi Kasei Pharma Corporation

INN (الاسم الدولي):

Teriparatide acetate

الشكل الصيدلاني:

injection

نشرة المعلومات

Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 10/2016
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
TERIPARATIDE ACETATE INJ.100 "ASAHI KASEI"
ACTIVE INGREDIENT:
Teriparatide acetate
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine is a synthetic human parathyroid hormone preparation. It
is a diagnostic agent
for parathyroid function.
It is usually used in the Ellsworth-Howard test.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have hypercalcemia.
・If you are pregnant, possibly pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         

to be written by a healthcare
professional
))
・In general, this medicine is injected intravenously gradually over
a period of 3 minutes or
longer, once at the time of inspection.
・Pay attention to the following points for accurate diagnosis.
(A) Standard method
1. Do not take phosphorus absorption inhibitor or calcium agents. If
you are taking these
agents, the inspection will be conducted approximately 1 week after
discontinuing those
agents.
2. The day before the inspection, do not take dairy products.
3. On the day of inspection, breakfast must be